Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;27(1):26-36.
doi: 10.1053/j.jrn.2016.07.001. Epub 2016 Aug 12.

Concurrence of Serum Creatinine and Albumin With Lower Risk for Death in Twice-Weekly Hemodialysis Patients

Affiliations

Concurrence of Serum Creatinine and Albumin With Lower Risk for Death in Twice-Weekly Hemodialysis Patients

Jialin Wang et al. J Ren Nutr. 2017 Jan.

Abstract

Objective: Markers of better nutritional status including both higher levels of serum albumin (as a measure of visceral proteins) and creatinine (as a measure of the muscle mass) are associated with lower mortality in conventional (thrice weekly) hemodialysis patients. However, data for these associations in twice-weekly hemodialysis patients, in whom less frequent hemodialysis may confound nutritional predictors, are lacking.

Design and subjects: We identified 1,113 twice-weekly and matched 4,448 thrice-weekly hemodialysis patients from a large national dialysis cohort of incident hemodialysis patients over 5 years (2007-2011). Mortality risk, adjusted for potential confounders, was examined across two-by-two combinations of serum creatinine (<6 vs. ≥6 mg/dL) and albumin (<3.5 g/dL vs. ≥3.5 g/dL) for each treatment frequency yielding a total of 8 groups.

Results: Patients were aged 70 ± 14 years and included 48% women and 55% diabetics. Using the thrice-weekly hemodialysis patients with creatinine ≥ 6 mg/dL and albumin ≥ 3.5 g/dL as reference, patients with creatinine <6 mg/dL and albumin <3.5 g/dL had a 1.8-fold higher risk of mortality (hazard ratio: 1.75, 95% confidence interval: 1.33-2.30) in twice-weekly and 2.2-fold increased risk of mortality (hazard ratio: 2.21, 95% confidence interval: 1.81-2.70) in thrice-weekly hemodialysis patients, respectively in fully adjusted models adjusted for demographics, comorbidities, and markers of malnutrition and inflammation. A test for interaction showed that there was no significant difference in albumin creatinine mortality associations between twice-weekly and thrice-weekly hemodialysis patients (P-for-interaction = .7667).

Conclusions: Surrogate markers of higher visceral protein and muscle mass combined may confer greatest survival in both twice-weekly and thrice-weekly hemodialysis patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cohort Construction
Figure 2
Figure 2
Baseline survival hazard ratio over 5 years according to concurrence of serum creatinine (mg/dl) and albumin (g/dl) in total after matched hemodialysis patients (n=5,561).
Figure 3
Figure 3
Baseline survival hazard ratio over 5 years according to concurrence of serum creatinine (mg/dl) and albumin (g/dl) in after matched twice-weekly hemodialysis patients (n=1,113).
Figure 4
Figure 4
Baseline survival hazard ratio over 5 years according to concurrence of serum creatinine (mg/dl) and albumin (g/dl) in after matched thrice-weekly hemodialysis patients (n=4,448).
Figure 5
Figure 5
Baseline survival hazard ratio over 5 years according to concurrence of serum creatinine (mg/dl) and albumin (g/dl) among after matched twice-weekly (n=1,113) and thrice-weekly (n=4,448) hemodialysis patients.

Similar articles

Cited by

References

    1. Shah SV, Feehally J. The third World Kidney Day: looking back and thingking forward. Clin J Am Soc Nephrol. 2008;3(2):309–311. - PMC - PubMed
    1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–2047. - PubMed
    1. US Renal Data System . USRDS 2012 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD: 2012.
    1. Keshaviah PR, Nolph KD, Moore HL, Prowant B, Emerson PF, Meyer M, Twardowski ZJ, Khanna R, Ponferrada L, Collins A. Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol. 1994;4(7):1475–1485. - PubMed
    1. Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG. Total plasma creatinine: an accurate measure of total striated muscle mass. J Appl Physiol Respir Environ Exerc Physiol. 1981;51(3):762–766. - PubMed

Publication types